2004
DOI: 10.1158/1078-0432.ccr-04-0871
|View full text |Cite
|
Sign up to set email alerts
|

Preradiotherapy Hemoglobin Level but not Microvessel Density Predicts Locoregional Control and Survival in Laryngeal Cancer Treated with Primary Radical Radiotherapy

Abstract: Purpose: To evaluate the roles of preradiotherapy hemoglobin level and microvessel density (MVD) as predictive factors for tumor control and survival in patients with laryngeal cancer treated with primary radiotherapy.Experimental Design: Two hundred and fourteen patients with stage I-IV laryngeal cancer were included in the analysis. Patients were treated with once daily fractionated radiotherapy over 6.5 weeks or twice daily fractionated radiotherapy over 4.5 weeks up to total doses of 62 to 68 Gy. Preradiot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 31 publications
0
3
0
Order By: Relevance
“…Although there are substantial data implying that poorly vascularized tumors are resistant to chemotherapy and/or radiotherapy, no definitive conclusion has been drawn at present on the clinical usefulness of MVD as a marker for prognosis. There are some studies that did not show a relationship between MVD and survival (18,19) and a reverse relationship between MVD and survival has been reported by some groups (20,21).…”
Section: Discussionmentioning
confidence: 94%
“…Although there are substantial data implying that poorly vascularized tumors are resistant to chemotherapy and/or radiotherapy, no definitive conclusion has been drawn at present on the clinical usefulness of MVD as a marker for prognosis. There are some studies that did not show a relationship between MVD and survival (18,19) and a reverse relationship between MVD and survival has been reported by some groups (20,21).…”
Section: Discussionmentioning
confidence: 94%
“…Anemia is an independent risk factor for survival in most cancers, especially in the context of curative radiotherapy (e.g., [42,61,69,71,77,105,132,137,145,[153][154][155][156][157]). Animal study data consistently show that correcting anemia with an ESA improves the response to radiotherapy or chemotherapy [102,145,156].…”
Section: Correction Of Anemia: From Animal Studiesmentioning
confidence: 99%
“…As the gold standard for evaluating tumor angiogenesis, MVD has been demonstrated to correlate with the subtypes of malignant tumors. In addition, the prognostic relevance of angiogenesis assessed by MVD has been reported in various tumor types, such as breast, liver, laryngeal, and nasopharyngeal cancers (79). Ki-67, one of the biological markers used to evaluate proliferation, is well characterized at the molecular level and is extensively used in tumor diagnosis, tumor grading, evaluation of tumor aggressiveness (10), treatment response, tumor recurrence, and survival rate in multiple cancers (1114).…”
Section: Introductionmentioning
confidence: 99%